Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TrendingWallStreet.com Initiates Analysis on FENG, NVIV, LIFS, and ZNGA

NVIVQ, FENG, LIFS

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.

Phoenix New Media Limited (NYSE: FENG) shares closed up 13.97 percent on about 3.8 million shares traded on Friday. The stock had a trading range of 9.65 - 10.38 that day and had one of the largest percentage increases on the NYSE. J.P. Morgan raised its Buy price target from $14 to $15.

Get more information on Phoenix New Media Limited and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/FENG

InVivo Therapeutics Holdings Corp. (OTC: NVIV) shares closed up 55.65 percent on Friday and traded about 2.1 million shares. The stock had one of the largest volume increases in the OTC market. The biomaterials company who has a focus on treatment of spinal cord injuries, confirmed that the company expects that the clinical trial of its first investigational product, a degradable polymer scaffold designed to promote healing following acute spinal cord injury, will be ready to enroll patients in the first quarter of 2014.

Get more information on InVivo Therapeutics Holdings Corp. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/NVIV

Life Stem Genetics Inc. (OTCBB: LIFS) shares closed up a modest 4.64 percent on Friday, much like Thursday when it also closed up about 4 percent. The company announced Friday that its Regenerative Specialist, James Vanden Bosch,BHA, has been given the title and responsibility of Chief Medical Stem Cell Specialist at Life Stem Genetics. Mr. Vanden Bosch has been in healthcare for more than a decade and has performed thousands of stem cell treatments on patients. The stock hit a new 52-week high that day of $1.58 with volume traded at nearly 700,000 shares.

Get more information on Life Stem Genetics Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/LIFS

Zynga, Inc. (NASDAQ: ZNGA) shares hit a new 52-week high of 4.12 last Friday on about 44 million shares traded, rough double what the stock usually sees. The stock closed modestly in the green with a gain of 2.81 percent. There was no significant news to drive the stock higher.

Get more information on Zynga, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ZNGA

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today